Prevalidation of an Acute Inhalation Toxicity Test Using the EpiAirwayIn VitroHuman Airway Model
Open Access
- 1 June 2018
- journal article
- research article
- Published by Mary Ann Liebert Inc in Applied In Vitro Toxicology
- Vol. 4 (2) , 149-158
- https://doi.org/10.1089/aivt.2018.0004
Abstract
Introduction: Knowledge of acute inhalation toxicity potential is important for establishing safe use of chemicals and consumer products. Inhalation toxicity testing and classification procedures currently accepted within worldwide government regulatory systems rely primarily on tests conducted in animals. The goal of the current work was to develop and prevalidate a nonanimal (in vitro) test for determining acute inhalation toxicity using the EpiAirway™ in vitro human airway model as a potential alternative for currently accepted animal tests. Materials and Methods: The in vitro test method exposes EpiAirway tissues to test chemicals for 3 hours, followed by measurement of tissue viability as the test endpoint. Fifty-nine chemicals covering a broad range of toxicity classes, chemical structures, and physical properties were evaluated. The in vitro toxicity data were utilized to establish a prediction model to classify the chemicals into categories corresponding to the currently accepted Globally Harmonized System (GHS) and the Environmental Protection Agency (EPA) system. Results: The EpiAirway prediction model identified in vivo rat-based GHS Acute Inhalation Toxicity Category 1–2 and EPA Acute Inhalation Toxicity Category I–II chemicals with 100% sensitivity and specificity of 43.1% and 50.0%, for GHS and EPA acute inhalation toxicity systems, respectively. The sensitivity and specificity of the EpiAirway prediction model for identifying GHS specific target organ toxicity-single exposure (STOT-SE) Category 1 human toxicants were 75.0% and 56.5%, respectively. Corrosivity and electrophilic and oxidative reactivity appear to be the predominant mechanisms of toxicity for the most highly toxic chemicals. Conclusions: These results indicate that the EpiAirway test is a promising alternative to the currently accepted animal tests for acute inhalation toxicity.Keywords
This publication has 17 references indexed in Scilit:
- Asthmatic Airway Epithelium Is Intrinsically Inflammatory and Mitotically DyssynchronousAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral EntryPLoS Pathogens, 2010
- A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In VivoThe Journal of Infectious Diseases, 2010
- Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developmentsExperimental and Toxicologic Pathology, 2008
- Alternative test methods in inhalation toxicology: Challenges and opportunitiesExperimental and Toxicologic Pathology, 2008
- An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethaneToxicology, 2008
- In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivoInternational Journal of Pharmaceutics, 2007
- Permeation of WIN 55,212-2, a potent cannabinoid receptor agonist, across human tracheo-bronchial tissue in vitro and rat nasal epithelium in vivoJournal of Pharmacy and Pharmacology, 2006
- Development of a novel high-concentration galantamine formulation suitable for intranasal deliveryJournal of Pharmaceutical Sciences, 2005
- Toxicity Assessment of Industrial Chemicals and Airborne Contaminants: Transition fromIn VivotoIn VitroTest Methods: A ReviewInhalation Toxicology, 2005